Treatment of hepatocellular carcinoma at the dawn of the third millennium: liver transplantation and its alternatives.
Hepatocellular carcinoma is one of the most frequent tumors worldwide, and its frequency is increasing. The management of hepatocellular carcinoma has changed in recent years, this because screening allows to discover tumors at an earlier stage, and because of effective treatments are available, such as liver transplantation, liver resection, percutaneous ablation and transarterial chemoembolization. Each one of these treatments has its own advantages and drawbacks, and range of application according to the stage of the tumor and of the underlying liver disease. This review summarizes the recent progress in the management of HCC and the practice in our unit.
Majno
P
P
Clinics of Visceral Surgery and Transplantation, University Hospitals of Geneva, Switzerland. Pietro.Majno@hcuge.ch
Mentha
G
G
Giostra
E
E
Terraz
S
S
Rubbia-Brandt
L
L
Berney
Th
T
Buhler
L
L
Toso
Ch
Ch
Huber
O
O
Spahr
L
L
Morard
I
I
Hadengue
A
A
Becker
Ch
Ch
Terrier
F
F
Morel
Ph
P
D006528:Carcinoma, Hepatocellular / Q000175:diagnosis / Q000601:surgery* / Q000628:therapy; D006801:Humans; D008113:Liver Neoplasms / Q000175:diagnosis / Q000601:surgery* / Q000628:therapy; D016031:Liver Transplantation; D008403:Mass Screening; D009367:Neoplasm Staging; D016896:Treatment Outcome